Insider Shareholders with Direct Ownership of Royalty Pharma PLC (RPRX)
This section provides a comprehensive overview of the insiders with direct ownership of Royalty Pharma PLC (RPRX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Royalty Pharma plc Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction | 
|---|---|---|---|---|---|
| 
                  
                    Legorreta Pablo G.
                  
                   CEO, Chairman of the Board | 840,601 | 733,000 | 904,396 $33.4 Million | 5 |                   
            Aug 06, 2025
              Added 2.36%
           | 
| 
                  
                    Rory B Riggs
                  
                   Director | 3,922,897 | 3,602,798 | 320,099 $11.8 Million | 33 |                   
            Feb 20, 2024
              Added 48.38%
           | 
| 
                  
                    Gregory Norden
                  
                   Director | 181,368 | 33,500 | 194,848 $7.2 Million | 7 |                   
            Aug 11, 2025
              Reduced 14.67%
           | 
| 
                  
                    Errol B Desouza
                  
                   Director | 36,708 | 0 | 81,352 $3.01 Million | 5 |                   
            May 13, 2025
              Added 8.56%
           | 
| 
                  
                    Bonnie L Bassler
                  
                   Director | 59,528 | 0 | 72,165 $2.67 Million | 26 |                   
            Sep 30, 2025
              Added 1.43%
           | 
| 
                  
                    Henry A Fernandez
                  
                   Director | 58,184 | 0 | 65,324 $2.41 Million | 25 |                   
            Jun 30, 2025
              Added 1.6%
           | 
| 
                  
                    Ted W Love
                  
                   Director | 36,708 | 0 | 53,848 $1.99 Million | 5 |                   
            May 13, 2025
              Added 12.39%
           | 
| 
                  
                    Catherine M. Engelbert
                  
                   Director | 37,618 | 0 | 51,128 $1.89 Million | 6 |                   
            May 13, 2025
              Added 12.96%
           | 
| 
                  
                    Marshall Urist
                  
                   EVP, Research & Investments | 228,956 | 143,033 | 39,256 $1.45 Million | 15 |                   
            Aug 06, 2025
              Added 6.6%
           | 
| 
                  
                    David C Hodgson
                  
                   Director | 33,328 | 0 | 33,328 $1.23 Million | 5 |                   
            May 13, 2025
              Added 18.6%
           | 
| 
                  
                    Vlad Coric
                  
                   Director | 10,798 | 0 | 10,798 $398,878 | 2 |                   
            May 13, 2025
              Added 41.35%
           | 
| 
                  
                    Carole Ho
                  
                   Director | 8,558 | 0 | 8,558 $316,132 | 1 |                   
            Jul 31, 2025
              Added 40.42%
           | 
| 
                  
                    Elizabeth H Weatherman
                  
                   Director | 8,558 | 0 | 8,558 $316,132 | 1 |                   
            Jul 31, 2025
              Added 40.42%
           | 
| 7,747 | 0 | 7,747 $286,174 | 1 |                   
            Jun 23, 2023
              Added 50.0%
           | |
| 
                  
                    William E Ford
                  
                   Director | 6,597 | 0 | 6,597 $243,693 | 2 |                   
            Jun 30, 2021
              Added 11.66%
           |